Evidence map›Paper›PMID 30755505›Full record

ArticlemBio2019

Nucleotide Resolution Comparison of Transcription of Human Cytomegalovirus and Host Genomes Reveals Universal Use of RNA Polymerase II Elongation Control Driven by Dissimilar Core Promoter Elements.

Mrutyunjaya Parida, Kyle A Nilson, Ming Li, Christopher B Ball, Harrison A Fuchs, Christine K Lawson, Donal S Luse, Jeffery L Meier, David H Price

Open access · goldAbstract readComparative Study
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. De novo assembly of RNA mCell reports · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Decoding murine cytomegalovirus.PLoS pathogens · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mrutyunjaya Parida *Department of Biochemistry, The University of Iowa, Iowa City, Iowa, USA.
Kyle A Nilson *Department of Biochemistry, The University of Iowa, Iowa City, Iowa, USA.
Ming LiDepartment of Biochemistry, The University of Iowa, Iowa City, Iowa, USA.
Christopher B BallDepartment of Biochemistry, The University of Iowa, Iowa City, Iowa, USA.
Harrison A FuchsDepartment of Biochemistry, The University of Iowa, Iowa City, Iowa, USA.
Christine K LawsonDepartment of Biochemistry, The University of Iowa, Iowa City, Iowa, USA.
Donal S LuseDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Jeffery L MeierDepartment of Internal Medicine and Epidemiology, The University of Iowa, Iowa City, Iowa, USA.
David H PriceDepartment of Biochemistry, The University of Iowa, Iowa City, Iowa, USA david-price@uiowa.edu.ORCID 0000-0002-5597-385X
University of Iowa · USCleveland Clinic Lerner College of Medicine · US

Funding

FACTORS INVOLVED IN TRANSCRIPTION BY RNA POLYMERSASE IIR01GM035500 · NIGMS · UNIVERSITY OF IOWA · PI PRICE, DAVID H · 1985 to 2017
$6.5M
RNA polymerase II elongation controlR35GM126908 · NIGMS · UNIVERSITY OF IOWA · PI PRICE, DAVID H · 2018 to 2022
$2.9M
Coordination of early events in RNA polymerase II elongation controlR01GM113935 · NIGMS · UNIVERSITY OF IOWA · PI LUSE, DONAL, PRICE, DAVID H · 2016 to 2017
$786k
Transcriptional Mechanisms Controlling HCMV InfectionR21AI130453 · NIAID · UNIVERSITY OF IOWA · PI MEIER, JEFFERY L, PRICE, DAVID H · 2018 to 2019
$347k
BLRD VA I01 BX001107BLRD VA I01 BX004434NIAID NIH HHS R21 AI130453NIGMS NIH HHS R01 GM035500NIGMS NIH HHS R01 GM113935NIGMS NIH HHS R35 GM126908
6 · The paper itself

Abstract

The large genome of human cytomegalovirus (HCMV) is transcribed by RNA polymerase II (Pol II). However, it is not known how closely this betaherpesvirus follows host transcriptional paradigms. We applied PRO-Seq and PRO-Cap methods to profile and quantify transcription initiation and productive elongation across the host and virus genomes in late infection. A major similarity between host transcription and viral transcription is that treatment of cells with the P-TEFb inhibitor flavopiridol preempts virtually all productive elongation, which otherwise covers most of the HCMV genome. The deep, nucleotide resolution identification of transcription start sites (TSSs) enabled an extensive analysis of core promoter elements. An important difference between host and viral transcription is that initiation is much more pervasive on the HCMV genome. The sequence preferences in the initiator region around the TSS and the utilization of upstream T/A-rich elements are different. Upstream TATA positions the TSS and boosts initiation in both the host and the virus, but upstream TATT has a significant stimulatory impact only on the viral template. The major immediate early (MIE) promoter remained active during late infection and was accompanied by transcription of both strands of the MIE enhancer from promoters within the enhancer. Surprisingly, we found that the long noncoding RNA4.9 is intimately associated with the viral origin of replication (oriLyt) and was transcribed to a higher level than any other viral or host promoter. Finally, our results significantly contribute to the idea that late in infection, transcription takes place on viral genomes that are not highly chromatinized.

Indexed as

Genome, HumanGenome, ViralPromoter Regions, GeneticTranscription Initiation, GeneticTranscription Initiation SiteCells, CulturedCytomegalovirusEnzyme InhibitorsFlavonoidsHumansPiperidinesRNA Polymerase IIalvocidibEnzyme InhibitorsFlavonoidsPiperidinesRNA Polymerase IIcore promoter elementscytomegalovirusPRO-SeqP-TEFbRNA4.9RNA polymerase II

Identifiers

PMID30755505
PMCPMC6372792
OpenAlexW2913823278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.